Plasmablastic lymphoma: An update.
Bailly J, Jenkins N, Chetty D, Mohamed Z, Verburgh ER, Opie JJ.
Int J Lab Hematol. 2022 Sep;44 Suppl 1(Suppl 1):54-63. doi: 10.1111/ijlh.13863.
Plasmablastic Lymphoma: Past, Present, and Future.
Kaur S, Kollimuttathuillam S.
Clin Lymphoma Myeloma Leuk. 2023 Sep;23(9):e253-e259. doi: 10.1016/j.clml.2023.05.014. Epub 2023 Jun 14.
Plasmablastic lymphoma: 2024 update on diagnosis, risk stratification, and management.
Ramirez-Gamero A, Martínez-Cordero H, Beltrán BE, Florindez J, Malpica L, Castillo JJ.
Am J Hematol. 2024 Aug;99(8):1586-1594. doi: 10.1002/ajh.27376. Epub 2024 May 20.
Plasmablastic lymphoma: current knowledge and future directions.
Li JW, Peng HL, Zhou XY, Wang JJ.
Front Immunol. 2024 Feb 13;15:1354604. doi: 10.3389/fimmu.2024.1354604. eCollection 2024.
Plasmablastic Lymphoma.
Bhatt R, Naha K, Desai DS.
2024 Feb 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
An Endotracheal Plasmablastic Lymphoma.
Bots EMT, Opperman J, Bassa F, Koegelenberg CFN.
Respiration. 2019;98(6):546-550. doi: 10.1159/000503586. Epub 2019 Oct 21.
Plasmablastic lymphoma: current perspectives.
Lopez A, Abrisqueta P.
Blood Lymphat Cancer. 2018 Oct 4;8:63-70. doi: 10.2147/BLCTT.S142814. eCollection 2018.
[Plasmablastic lymphoma].
Fernández-Álvarez R, Sancho JM, Ribera JM.
Med Clin (Barc). 2016 Nov 4;147(9):399-404. doi: 10.1016/j.medcli.2016.06.036. Epub 2016 Aug 28.
Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma.
Castillo JJ, Guerrero-Garcia T, Baldini F, Tchernonog E, Cartron G, Ninkovic S, Cwynarski K, Dierickx D, Tousseyn T, Lansigan F, Linnik Y, Mogollon R, Navarro JT, Olszewski AJ, Reagan JL, Fedele P, Gilbertson M, Grigoriadis G, Bibas M.
Br J Haematol. 2019 Feb;184(4):679-682. doi: 10.1111/bjh.15156. Epub 2018 Mar 12.
Plasmablastic lymphoma: one or more tumors?
Pileri SA, Mazzara S, Derenzini E.
Haematologica. 2021 Oct 1;106(10):2542-2543. doi: 10.3324/haematol.2021.278841.
